Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Street, Wuhan 430030, People’s Republic of China.
Nephrol Dial Transplant. 2011 Jun;26(6):1932-7. doi: 10.1093/ndt/gfq667. Epub 2010 Nov 5.
The Modification of Diet in Renal Disease (MDRD) equation is widely used for the estimation of glomerular filtration rate (GFR) from plasma creatinine. It has been well validated in patients with various degrees of impaired kidney function, but not in patients with end-stage renal disease (ESRD). Plasma creatinine is determined by GFR and muscle mass. Importance of the latter may increase at low GFR. Our aim was to firstly compare estimated GFR (eGFR by MDRD equation) with measured GFR (mGFR, mean of creatinine and urea clearance) just before the start of dialysis. Secondly, the relationship of eGFR and mGFR with mortality and muscle mass was analysed.
ESRD patients with 24-h urine collections and a plasma sample available at the start of dialysis [n = 569, 61% male, mean (standard deviation) age 58 (15) years] were selected from the Netherlands Cooperative Study on the Adequacy of Dialysis. Incident dialysis patients were followed until death, transplantation or end of study.
mGFR was 6.0 (2.6) and eGFR was 6.8 (2.4) mL/min/1.73 m(2). Although eGFR overestimated mGFR with only 0.8 mL/min/1.73 m(2), limits of agreement ranged from - 4.1 to + 5.6 mL/min/1.73 m(2). The highest eGFR values were associated with the highest mortality rates [adjusted hazard ratio 1.4 (1.0, 1.9)]. eGFR but not mGFR was associated with muscle mass (P = 0.001).
These data imply that estimation of GFR by equations using plasma creatinine in the denominator cannot be used for this purpose in patients with ESRD because the effect of GFR on plasma creatinine is overruled by that of muscle mass.
改良肾脏病饮食研究(MDRD)方程被广泛用于通过血浆肌酐估算肾小球滤过率(GFR)。该方程已在各种程度肾功能不全的患者中得到了很好的验证,但尚未在终末期肾病(ESRD)患者中进行验证。血浆肌酐由 GFR 和肌肉量决定。在低 GFR 时,后者的重要性可能会增加。我们的目的首先是比较开始透析前刚刚测定的 GFR(MDRD 方程估算的 GFR[eGFR])和测量的 GFR(肌酐和尿素清除率的平均值[mGFR])。其次,分析 eGFR 和 mGFR 与死亡率和肌肉量的关系。
从荷兰透析充分性合作研究中选择了有 24 小时尿液收集和透析开始时的血浆样本的 ESRD 患者(n=569,61%为男性,平均[标准差]年龄 58[15]岁)。观察性队列研究,起始时所有患者均开始透析。对所有进入队列的患者进行随访,直至死亡、移植或研究结束。
mGFR 为 6.0(2.6)mL/min/1.73m2,eGFR 为 6.8(2.4)mL/min/1.73m2。虽然 eGFR 仅比 mGFR 高估了 0.8 mL/min/1.73m2,但一致性界限范围为-4.1 至+5.6 mL/min/1.73m2。最高的 eGFR 值与最高的死亡率相关[校正后的危险比 1.4(1.0,1.9)]。eGFR 而不是 mGFR 与肌肉量相关(P=0.001)。
这些数据表明,在 ESRD 患者中,使用血浆肌酐作为分母的方程估算 GFR 不能用于该目的,因为 GFR 对血浆肌酐的影响被肌肉量所掩盖。